The appropriateness of treatment of benign prostatic hyperplasia: A comparison of Dutch and multinational criteria

Health Policy

Volumn 57, Issue 1, 2001, Pages 45-56

  McDonnell, Joseph ^a   Stoevelaar, Herman J ^a   Ruud Bosch, J L H ^b   Kahan, James P ^c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c RAND CORPORATION   (United States)

Author keywords

Appropriateness; Modified Delphi process; Reproducibility of appropriateness criteria

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; FINASTERIDE;

ARTICLE; EUROPE; HEALTH CARE; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL COOPERATION; MALE; NETHERLANDS; ORGANIZATION; PRACTICE GUIDELINE; PROSTATE HYPERTROPHY; RATING SCALE; STANDARD; TREATMENT INDICATION; UROLOGIC SURGERY; UROLOGY;

AGED; CLINICAL PROTOCOLS; DELPHI TECHNIQUE; EUROPE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PRACTICE GUIDELINES; PROSTATIC HYPERPLASIA; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 0035036123     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(01)00127-0     Document Type: Article

References (15)

1. Isaacs J.T., Coffey D.S. Etiology and disease process of benign prostatic hyperplasia. Prostate. Suppl. 2:1989;33-50.
2. Jacobsen S.J., Girman C.J., Guess H.A., Oesterling J.E., Lieber M.M. New diagnostic treatment guidelines for benign prostatic hyperplasia. Archives of Internal Medicine. 155:1995;477-481.
3. Stoevelaar H.J., van de Beek K., Casparie A.F., Nijs H.G.T., McDonnell J., Janknegt R.A. Variation in urologists' opinions on treatment choice in benign prostatic hyperplasia. European Journal of Public Health. 7:1997;341-344.
4. Stoevelaar H.J., Van de Beek C., Casparie A.F., McDonnell J., Nijs H.G.T. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference? J. Urol. 161:1999;133-138.
5. McConnell J.D., Barry M.J., Bruskewitz R.C., Bueschen A.J., Denton S.E., Holtgrewe H.L., Lange J.L., McClennan B.L., Mebust W.K., Reilly N.J., Roberts R.G., Sacks S.A., and Easson J.H. Clinical practice guideline for benign prostatic hyperplasia: diagnosis and treatment. Rockville, MD: Department of Health and Human Services, 1994. AHCPR publication no.94-0582.
6. Denis L., Griffiths K., Khoury S., Cockett A.T.K., McConnell J., Chatelain C., Murphy G., and Yoshida Y. (editors). Proceedings of the 4th International Consultation on Benign Prostatic Hyperplasia (BPH): 1997 Jul 2-5: Paris. Plymouth: Health Publication Ltd, 1998.
7. Meijler A.P., Rigter H., Bernstein S.J., Scholma J.K., McDonnell J., Breeman A., Kosecoff J.B., Brook R.H. The appropriateness of intention to treat decisions for invasive therapy in coronary artery disease in the Netherlands. Heart. 77:1997;219-224.
8. McGlynn E.A., Naylor C.D., Anderson G.M., Leape L.L., Park R.E., Hilborne L.H., Bernstein S.J., Goldman B.S., Armstrong P.W., Keesy J.W. Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State. J. Am. Med. Assoc. 272:1994;934-950.
9. Froehlich F., Pache I., Burnand B., Vader J.P., Fried M., Kosecoff J., Kolodny M., DuBois R.W., Brook R.H., Gonvers J.J. Underutilization of upper gastrointestinal endoscopy. Gastroenterology. 112:1997;690-697.
10. Fitch K., and Làzaro P. Using appropriateness criteria to improve health care, Eurohealth, 5 (1999) 19-21.
11. Vader J.P., Burnand B. Prospective assessment of appropriateness of the health care. Eurohealth. 5:1999;21-23.
12. Stoevelaar H.J., McDonnell J., Van de Beek C., Casparie A.F. Appropriate treatment of benign prostatic hyperplasia; refining the indications for treatment by systematic analysis of expert opinion (in Dutch). Nederlands Tijdschrift voor Geneeskunde. 143:1999;2425-2429.
13. Stoevelaar H.J., McDonnell J., Bosch J.L.H.R., Kahan J.P., and van het Loo M. Appropriate Treatment of benign prostatic hyperplasia: a European panel study. Leiden: RAND Europe report RE99.017 (1999).
14. Stoevelaar H.J., McDonnell J. Changing therapeutic regimens in benign prostatic hyperplasia: clinical and economic considerations. Pharmacoeconomics (in press).
15. Agresti A. Categorical Data Analysis. 1989;John Wiley and Sons, New York.